Eli Brazowski

3.2k total citations
73 papers, 2.4k citations indexed

About

Eli Brazowski is a scholar working on Oncology, Surgery and Immunology. According to data from OpenAlex, Eli Brazowski has authored 73 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 21 papers in Surgery and 20 papers in Immunology. Recurrent topics in Eli Brazowski's work include Inflammatory Bowel Disease (11 papers), Pancreatic and Hepatic Oncology Research (9 papers) and Genetic factors in colorectal cancer (9 papers). Eli Brazowski is often cited by papers focused on Inflammatory Bowel Disease (11 papers), Pancreatic and Hepatic Oncology Research (9 papers) and Genetic factors in colorectal cancer (9 papers). Eli Brazowski collaborates with scholars based in Israel, United States and France. Eli Brazowski's co-authors include Zamir Halpern, Chen Varol, Ehud Zigmond, Metsada Pasmanik‐Chor, Iris Dotan, Oren Shibolet, Shirley Abramovitch, Hagit Tulchinsky, Erwin Santo and Y. Weisman and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Gastroenterology.

In The Last Decade

Eli Brazowski

71 papers receiving 2.4k citations

Peers

Countries citing papers authored by Eli Brazowski

Since Specialization

Citations

This map shows the geographic impact of Eli Brazowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli Brazowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli Brazowski more than expected).

Fields of papers citing papers by Eli Brazowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eli Brazowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli Brazowski. The network helps show where Eli Brazowski may publish in the future.

Co-authorship network of co-authors of Eli Brazowski

This figure shows the co-authorship network connecting the top 25 collaborators of Eli Brazowski. A scholar is included among the top collaborators of Eli Brazowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eli Brazowski. Eli Brazowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Relationship between Treatment Response and Overall Survival in Borderline, Non-Resectable and Resectable Pancreatic Cancer Patients Treated with Neoadjuvant FOLFIRINOX 2024 ·Journal of Clinical Medicine ·(unknown), (unknown), Kapil Sahnan, (unknown), Or Goren, Sharon Halperin, Eli Brazowski, (unknown), Joseph M. Klausner, Nir Lubezky	1
2	Immune cell C/EBPβ deficiency is associated with hepatic mononuclear defects and spontaneous hepatitis but not steatohepatitis induced liver fibrosis 2022 ·Immunity Inflammation and Disease ·(unknown), Ayelet Kaminitz, Debby Reuveni, Metsada Pasmanik‐Chor, Eli Brazowski, Alexander Mildner, Achim Leutz, Ehud Zigmond	3
3	COMMD10 is critical for Kupffer cell survival and controls Ly6Chi monocyte differentiation and inflammation in the injured liver 2021 ·Cell Reports ·Keren Cohen, (unknown), (unknown), (unknown), (unknown), Noam Erez, (unknown), (unknown), Daniel Kedar, Eli Brazowski, Martin Guilliams, Helen S. Goodridge, Nathan Gluck, Chen Varol	12
4	Increased Rate of Complete Pathologic Response After Neoadjuvant FOLFIRINOX for BRCA Mutation Carriers with Borderline Resectable Pancreatic Cancer 2020 ·Annals of Surgical Oncology ·Talia Golan, (unknown), Guy Lahat, Ido Nachmany, (unknown), Einat Shacham‐Shmueli, Naama Halpern, Eli Brazowski, Ravit Geva, Ido Wolf, Yuri Goldes, Menahem Ben‐Haim, Joseph M. Klausner, Nir Lubezky	51
5	Neoadjuvant FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer: An intention to treat analysis 2018 ·European Journal of Surgical Oncology ·(unknown), Guy Lahat, Ravit Geva, Ido Nachmany, Richard Nakache, Yaacov Goykhman, Eli Brazowski, Galia Rosen, Ofer Isakov, Ido Wolf, Joseph M. Klausner, Nir Lubezky	71
6	Solid pseudopapillary neoplasm of the pancreas: Management and long-term outcome 2017 ·European Journal of Surgical Oncology ·Nir Lubezky, M. Papoulas, Yonatan Lessing, Gilad Gitstein, Eli Brazowski, Ido Nachmany, Guy Lahat, (unknown), Amir Ben Yehuda, Richard Nakache, Joseph M. Klausner	73
7	Serum Alpha-1 Antitrypsin 2015 ·Inflammatory Bowel Diseases ·Shay Matalon, (unknown), Eli Brazowski, Erwin Santo, Hagit Tulchinsky, Iris Dotan	10
8	Gene expression alterations in ulcerative colitis patients after restorative proctocolectomy extend to the small bowel proximal to the pouch 2014 ·Gut ·Henit Yanai, Shay Ben‐Shachar, (unknown), (unknown), Gilad Gitstein, Eli Brazowski, Hagit Tulchinsky, Metsada Pasmanik‐Chor, Iris Dotan	27
9	MicroRNA expression signatures in intraductal papillary mucinous neoplasm of the pancreas 2013 ·Surgery ·Nir Lubezky, (unknown), Menahem Ben‐Haim, Eli Brazowski, Sylvia Marmor, Metsada Pasmanik‐Chor, Varda Oron‐Karni, Gideon Rechavi, Joseph M. Klausner, Guy Lahat	40
10	Prevention of Induced Colitis in Mice by the Ras Antagonist Farnesylthiosalicylic Acid 2011 ·Digestive Diseases and Sciences ·Tal Oron, Galit Elad‐Sfadia, Roni Haklai, (unknown), Eli Brazowski, Yoel Kloog, Shimon Reif	10
11	Utilization of Murine Colonoscopy for Orthotopic Implantation of Colorectal Cancer 2011 ·PLoS ONE ·Ehud Zigmond, Zamir Halpern, Eran Elinav, Eli Brazowski, Steffen Jung, Chen Varol	51
12	A novel assessment of the quality of immunohistostaining overcomes the limitations of current methods 2008 ·Pathology - Research and Practice ·Avi Eisenthal, (unknown), Alexander Shtabsky, (unknown), Eli Brazowski	1
13	Rofecoxib Reduces Polyp Recurrence in Familial Polyposis 2003 ·Digestive Diseases and Sciences ·Aharon Hallak, (unknown), Raanan Shamir, Menachem Moshkowitz, (unknown), Eli Brazowski, Zamir Halpern, Nadir Arber	68
14	Endometriosis, Pregnancy, and Colonoscopy 2003 ·Endoscopy ·(unknown), Letizia Schreiber, Eli Brazowski	5
15	Granulomatosis Cheilitis and Crohn Disease 2001 ·Journal of Pediatric Gastroenterology and Nutrition ·Raz Somech, Avikam Harel, (unknown), Eli Brazowski, Shimon Reif	2
16	Granulomatosis Cheilitis and Crohn Disease 2001 ·Journal of Pediatric Gastroenterology and Nutrition ·Raz Somech, Avikam Harel, (unknown), Eli Brazowski, Shimon Reif	8
17	Focal Nodular Hyperplasia in Children 2001 ·Journal of Pediatric Gastroenterology and Nutrition ·Raz Somech, Eli Brazowski, (unknown), (unknown), (unknown), A. Martin Lerner, (unknown)	10
18	Time course of lipopolysaccharide-induced nitric oxide synthase mRNA expression in rat glomeruli 1999 ·Journal of Laboratory and Clinical Medicine ·Kobi Sade, Doron Schwartz, (unknown), Idit F. Schwartz, Tamara Chernichovski, Miriam Blum, Eli Brazowski, (unknown), Itamar Raz, Roland C. Blantz, Adrian Iaina	34
19	Rheumatoid nodules in a patient with primary antiphospholipid (Hughes) syndrome 1998 ·Lupus ·Ori Elkayam, Michal Yaron, Eli Brazowski, Dan Caspi	5
20	Case report: Mucocele formation 20 years after an appendiceal uterine transplantation for infertility mistaken for hydrops tubae profluens 1996 ·Human Reproduction ·(unknown), J. B. Lessing, Eli Brazowski, Amnon Botchan, Yair Daniel, M. Reuben Peyser	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact